| 000 | 01628 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515173649.0 | ||
| 264 | 0 | _c20090723 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1520-6025 | ||
| 024 | 7 |
_a10.1021/np900099j _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTapiolas, Dianne M | |
| 245 | 0 | 0 |
_aEusynstyelamides A, B, and C, nNOS inhibitors, from the ascidian Eusynstyela latericius. _h[electronic resource] |
| 260 |
_bJournal of natural products _cJun 2009 |
||
| 300 |
_a1115-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xchemistry |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNuclear Magnetic Resonance, Biomolecular |
| 650 | 0 | 4 |
_aPyruvate, Orthophosphate Dikinase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aUrochordata _xchemistry |
| 700 | 1 | _aBowden, Bruce F | |
| 700 | 1 | _aAbou-Mansour, Eliane | |
| 700 | 1 | _aWillis, Richard H | |
| 700 | 1 | _aDoyle, Jason R | |
| 700 | 1 | _aMuirhead, Andrew N | |
| 700 | 1 | _aLiptrot, Catherine | |
| 700 | 1 | _aLlewellyn, Lyndon E | |
| 700 | 1 | _aWolff, Carsten W W | |
| 700 | 1 | _aWright, Anthony D | |
| 700 | 1 | _aMotti, Cherie A | |
| 773 | 0 |
_tJournal of natural products _gvol. 72 _gno. 6 _gp. 1115-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/np900099j _zAvailable from publisher's website |
| 999 |
_c18928582 _d18928582 |
||